Chemotherapy in hormone-refractory prostate cancer: Docetaxel with and without VT122

Category Primary study
JournalJournal of Clinical Oncology
Year 2013
This article has no abstract
Epistemonikos ID: 56453d9be68baa3c2ec5cec41a3db6a779ba8236
First added on: Feb 05, 2025